clinical trial data

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

R&D

Beyond clinical: Boosting recruitment and retention with SDO...

The success of clinical trials hinges on a complex array of factors, many of which extend beyond traditional clinical care.

Patients

On Pfizer’s initiative to return clinical trial data to pati...

Among the most common reasons for dropping out, patients cite a lack of communication about the trial

R&D

Dangerous data delays – a real-time problem

Delayed clinical trial data delivery is a growing problem for pharmaceutical companies and one that can have catastrophic consequences for the development of their promising pipeline candid

R&D

Vaccines trials in the COVID-19 era and tech's role in speed...

Overview The COVID-19 outbreak has exposed the challenges pharmaceutical companies face as they race to develop a coronavirus vaccine.

Views & Analysis

How to address racial disparities in clinical trial data

In the US, fewer than three per cent of eligible patients participate in clinical trials – a figure that drops drastically when applied to ethnic minorities living in underserved communities.

Events

Partner Content

Blockchain for Pharma: Research & Clinical Development 2...

Effective Adoption & Real-world Application of BC